登入選單
返回Google圖書搜尋
Global Clinical Trials for Alzheimer’s Disease
Yağız ÜresinHilal İlbarsİbrahim Hakan GürvitMurat Emre
其他書名
Chapter 17. Experience in Alzheimer’s Disease Clinical Trials in Turkey
出版Elsevier Inc. Chapters, 2013-08-28
主題Medical / Clinical MedicineMedical / NeuroscienceScience / Life Sciences / BiologyMedical / PharmacologyMedical / NeurologyScience / Life Sciences / GeneralMedical / Psychiatry / Psychopharmacology
ISBN01280705289780128070529
URLhttp://books.google.com.hk/books?id=h5JzDAAAQBAJ&hl=&source=gbs_api
EBookSAMPLE
註釋Turkey straddles the continents of Europe and Asia, and this unique geographical location steers its economy. On the world economic scale, as an exceptional emerging economy, Turkey is the 16th largest economy in the world and the sixth largest economy as compared with the European Union countries, according to gross domestic product. The Turkish pharmaceutical sector is ranked 16th in terms of market value, and it is 36th in terms of the clinical research conducted and the volume of pharmaceutical exports. Investments by foreign companies have increased since 1984 and 19 foreign capital firms have entered the Turkish pharmaceuticals market since 1990. Today, there are approximately 300 entities operating in Turkey. Turkey has a long tradition of providing clinical trial legislation, regulation and guidelines; the country has taken major steps towards harmonizing its legislation with those of the European Union in the field of clinical research. Currently Turkish regulations are completely in line with EC Directives. Clinical trials performed in the field of Alzheimer’s disease in Turkey since 1997, including their rationale, design, summary, and outcomes, are discussed in this chapter.